Literature DB >> 35463851

Current clinical state of type 1 diabetes in Saitama prefecture.

Yoichi Oikawa1, Koshi Hashimoto2, Kazuo Hara3, Jiro Morimoto4, Kazuyuki Namai5, Akihiko Tanaka6, Satoshi Tanaka7, Akira Shimada1.   

Abstract

Introduction: In Japan, epidemiological studies on type 1 diabetes (T1D) have mainly focused on the disease in childhood. Meanwhile, limited information is available regarding the clinical features of adolescent and adult T1D. Therefore, we aimed to investigate their current clinical state in Saitama prefecture near Tokyo, Japan. Materials and methods: We conducted a cross-sectional, hospital-based, multicenter study. Eight institutions participated in the study, all of which treated relatively large numbers of T1D patients. We identified 1241 T1D patients aged 16 or over: 814 with acute-onset T1D (AT1D), 362 with slowly progressive insulin-dependent diabetes mellitus (SPIDDM), and 65 with fulminant T1D (FT1D). Based on the patient's medical records, various clinical parameters and complications were investigated.
Results: Of 1241 patients, 739 (59.5%) were females. Among all patients, the median age, onset age, and disease duration were 51, 38, and 13 years, respectively. The patients had a median BMI of 22.6 kg/m2, and 26.1% were obese, corroborating previous nationwide surveys. Moreover, the median HbA1c was 7.8%, similar to previous nationwide surveys. Among patients with AT1D, SPIDDM, and FT1D, 85.6%, 72.1%, and 81.5% carried out multiple daily insulin injection, respectively, while 10.3%, 2.2%, and 18.5% were subject to continuous subcutaneous insulin infusion. The proportions of retinopathy, nephropathy, and neuropathy were 26.3%, 20.8%, and 21.5%. Conclusions: The glycemic control in T1D patients in Saitama was equivalent to that observed in previous nationwide surveys. Moreover, approximately one-quarter of T1D patients had obesity. Future studies should address whether our findings reflect those throughout Japan. Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-021-00557-8. © The Japan Diabetes Society 2021.

Entities:  

Keywords:  Body mass index; Clinical picture; Complications; HbA1c; Saitama prefecture; Type 1 diabetes

Year:  2021        PMID: 35463851      PMCID: PMC8980132          DOI: 10.1007/s13340-021-00557-8

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  22 in total

1.  Incidence and prevalence of childhood-onset Type 1 diabetes in Japan: the T1D study.

Authors:  Y Onda; S Sugihara; T Ogata; S Yokoya; T Yokoyama; N Tajima
Journal:  Diabet Med       Date:  2017-02-02       Impact factor: 4.359

Review 2.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

Review 3.  Type 1 diabetes in Japan.

Authors:  E Kawasaki; N Matsuura; K Eguchi
Journal:  Diabetologia       Date:  2006-03-28       Impact factor: 10.122

4.  Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.

Authors:  Eiji Kawasaki; Kan Nakamura; Genpei Kuriya; Tsuyoshi Satoh; Masakazu Kobayashi; Hironaga Kuwahara; Norio Abiru; Hironori Yamasaki; Nobuo Matsuura; Junnosuke Miura; Yasuko Uchigata; Katsumi Eguchi
Journal:  Clin Immunol       Date:  2010-11-10       Impact factor: 3.969

5.  Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy--a nationwide 5-year-study in Japan.

Authors:  Y Murase; A Imagawa; T Hanafusa; H Iwahashi; Y Uchigata; A Kanatsuka; E Kawasaki; T Kobayashi; A Shimada; I Shimizu; T Maruyama; H Makino
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

6.  Fulminant type 1 diabetes: The clinical and continuous glucose monitoring characteristics in Chinese patients.

Authors:  Lingwen Ying; Xiaojing Ma; Jingyi Lu; Wei Lu; Wei Zhu; Robert A Vigersky; Weiping Jia; Yuqian Bao; Jian Zhou
Journal:  Clin Exp Pharmacol Physiol       Date:  2019-06-17       Impact factor: 2.557

7.  Rate of beta-cell destruction in type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual beta-cell function for more than 10 years.

Authors:  Koji Nakanishi; Chizuru Watanabe
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

8.  Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012).

Authors:  Akihisa Imagawa; Toshiaki Hanafusa; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Eiji Kawasaki; Yumiko Kawabata; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Kazuma Takahashi; Masao Nagata; Hideichi Makino; Taro Maruyama
Journal:  J Diabetes Investig       Date:  2012-11-30       Impact factor: 4.232

9.  Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus.

Authors:  Gudrun Leidig-Bruckner; Sonja Grobholz; Thomas Bruckner; Christa Scheidt-Nave; Peter Nawroth; Jochen G Schneider
Journal:  BMC Endocr Disord       Date:  2014-04-11       Impact factor: 2.763

10.  On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes.

Authors:  Takeshi Horii; Yoichi Oikawa; Koichiro Atsuda; Akira Shimada
Journal:  J Diabetes Investig       Date:  2021-02-16       Impact factor: 4.232

View more
  1 in total

1.  Multifocal Neuroarthropathy of the Knee and Foot Induced by Physical Training of the Lower Extremities in a Patient With Latent Autoimmune Diabetes in Adults.

Authors:  Chika Kojima; Tatsuhito Himeno; Machiko Akao; Hideki Kamiya; Jiro Nakamura
Journal:  Cureus       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.